Key result
High IL-8 linked to ~157% higher 10-year mortality in chronic heart failure.
Why the study?
Inflammation is increasingly recognized in chronic heart failure progression, but the association of cytokine and chemokine profiles with mild cognitive impairment and long-term mortality required investigation.
Do high interleukin-8 serum levels predict all-cause mortality and mild cognitive impairment in patients with chronic heart failure?
Cohort (n=145)
No
Do high interleukin-8 serum levels predict all-cause mortality and mild cognitive impairment in patients with chronic heart failure?
High serum IL-8 levels independently predict long-term all-cause mortality in patients with chronic heart failure, suggesting its potential as a prognostic biomarker.
Answers are grounded in this paper and cite their sources.
May refine risk stratification in chronic HF; hypothesis-generating for IL-8 as therapeutic target.
Background Chronic heart failure (HF) is a complex syndrome with significant morbidity and mortality, where inflammation is increasingly recognized as a critical factor in its progression. This study investigated the association of cytokine and chemokine profiles with mild cognitive impairment (MCI) and long-term mortality in patients with chronic HF. Methods Serum concentrations of 13 cytokines were measured in 145 patients from the Cognition.Matters-HF study baseline cohort using a bead-based multiplex assay. Detailed clinical and cognitive evaluations were conducted, and survival data were tracked over 10 years. Cox proportional hazards regression and logistic regression models were applied to assess independent associations with mortality and MCI. Results No cytokine was independently associated with MCI. However, high interleukin-8 (IL-8) levels (>5.3 pg/ml) were significantly and independently associated with all-cause mortality (HR: 2.30; 95% CI: 1.30–4.07; p = 0.004). After adjusting for age and sex, IL-8 remained a strong predictor (Adj. HR: 2.28; 95% CI: 1.29–4.05; p = 0.005). Further adjustments for clinical and biochemical variables showed that IL-8 (Adj. HR: 3.31; 95% CI: 1.61–6.79; p = 0.001) was the only cytokine independently associated with mortality. In the final multivariable model, IL-8 (Adj. HR: 2.57; 95% CI: 1.44–4.57; p = 0.001) remained a significant predictor along with age, body mass index, left atrial volume index, and six-minute walk distance. Other cytokines, including IL-6 and tumor necrosis factor-α, showed no independent associations with mortality. Conclusions These findings suggest IL-8's unique role in HF pathophysiology and its potential as a biomarker and therapeutic target. Further research is needed to validate these results and explore the clinical utility of IL-8 modulation in HF management.
No takes yet. Share an insight, caveat, or question.
Traub et al. (2025) conducted a cohort in Chronic heart failure (n=145). High interleukin-8 (IL-8) serum levels (>5.3 pg/ml) vs. IL-8 levels ≤ 5.3 pg/ml was evaluated on 10-year all-cause mortality (Adj. HR 2.57, 95% CI 1.44-4.57, p=0.001). High interleukin-8 serum levels (>5.3 pg/ml) independently predicted a 2.57-fold increased risk of 10-year all-cause mortality in patients with chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: